F.
NO. 8 (11)/2006/DP/NPPA-Div.II
GOVERNMENT
OF INDIA
MINISTRY
OF CHEMICALS AND FERTILIZERS
NATIONAL
PHARMACEUTICAL PRICING AUTHORITY
NEW
DELHI, DATED THE 7/2/2006
ORDER
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;
Price Excise Duty (Rs.) with ExciseDuty
(Rs.) (Rs.) (Rs.)
(1) (2) (3) (4) (5) (6) (7)
1 Humanext
N 10ml 117.28 117.02 0.00 117.02
Each
ml. Contains : Vial
Insulin
Human Ph. Eur.- 40 IU
(Insulin
Human of Recombinent DNA Origin)
m-Cresol
– 0.16% w/v
Phenol
– 0.065%
2 Humanext
30/70 10ml 121.80 117.36 0.00 117.36
Each
ml. Contains : Vial
Insulin
Human Ph. Eur.- 40 IU
(30%
as Soluble Insulin Injection
and
70% as Isophane Insulin Injection)
m-Cresol
– 0.16% w/v
Phenol
– 0.065%
3 Humarap 10ml 117.20 117.02 0.00 117.02
Each
ml. Contains : Vial
Insulin
Human Ph. Eur.- 40 IU
(Insulin
Human of Recombinent DNA Origin)
m-Cresol
– 0.25% w/v
2. This
order shall be applicable if the manufacturer of the formulation specified in
column (2) of the Table above has complied with the requirements, if any, of
(a) the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
(b) the Industries (Development and
Regulation) Act, 1951 (65 of 1951) as amended from time to time.
3. (a) The prices fixed/revised are the maximum retail prices (inclusive of excise duty and exclusive of local taxes, if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) For different packing material used or
any special feature claimed, companies are required to approach NPPA for
approval/fixation of specific prices.
4. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
M/s. Cadila Pharma Ltd. (A.
K. PAL)
Cadila
Corporate Campus,
Dy. Director
Sarkhej –
Dholka Road,
Bhat, Ahmedabad
– 382 210